Canine Adenovirus Type 2, Strain Manhattan, 12-13-76;Canine Coronavirus, Strain

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2310.0%

Death Rate

Active Ingredients

Canine Adenovirus Type 2, Strain Manhattan, 12-13-76;Canine Coronavirus, Strain

Administration Routes

Subcutaneous

Species Affected

Dog 13

Most Affected Breeds

Retriever - Labrador 3

Chihuahua 2

Shepherd Dog - Belgian Malinois 1

Terrier - Yorkshire 1

Crossbred Canine/dog 1

Dalmatian 1

Siberian Husky 1

Terrier - Jack Russell 1

Spaniel - Springer English 1

Schnauzer - Miniature 1

Most Reported Reactions

Vomiting 5

Lethargy (see also Central nervous system depression in 'Neurological') 2

Weight loss 2

Not eating 2

Eosinopenia 2

Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 2

Death 2

Medication error NOS 2

Decreased appetite 1

Third eyelid extrusion 1

Anal and rectal disorder NOS 1

Anaemia NOS 1

Outcome Breakdown

Ongoing

7 (46.7%)

Recovered/Normal

3 (20.0%)

Outcome Unknown

2 (13.3%)

Died

2 (13.3%)

Euthanized

1 (6.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.